An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type ...

US biotech Aldeyra Therapeutics is making another attempt to gain marketing approval for its eye drop treatment reproxalap, a ...

If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...

Rigel Pharmaceuticals Inc (RIGL) reports a 68% increase in net product sales and outlines promising developments for 2025.

Q1 2025 Earnings Call Transcript May 6, 2025 Dynavax Technologies Corporation misses on earnings expectations. Reported EPS is $0.01 EPS, expectations were $0.03. Operator: Good day ladies and ...

The biosimilar SYSA1902 is similar to reference ustekinumab for both efficacy and safety measures among patients with plaque psoriasis.

Equity Insider News Commentary ? Right after the world's largest gold-buying market (China) returned from its holiday break, gold prices resumed their climb, also helping reignite momentum across gold ...

Additional information regarding these results and other relevant information is included in the notes to the financial statements in “Item 18. Financial Statements”, which are included in InflaRx’s ...

Treatment with givinostat has received fast track designation from the United States Food and Drug Administration for ...

Announces successful completion of sub-chronic and chronic toxicology studies for INF904, supporting long-term dosing in future clinical trialsMultiple near-term catalysts anticipated with the potenti ...

At March 31, 2025, the Company's cash and cash equivalents grew to $938.5 million, compared to $912.8 million at December 31, 2024, after prepaying a $50.0 million deposit related to our Evergreen ...

A very low-carb diet significantly improved the pancreas’s ability to produce insulin in people with mild Type 2 diabetes ...